Check here for the latest on COVID-19 diagnosis and treatment
This Viewpoint discusses barriers to quality end-of-life care during the COVID-19 pandemic, including limited staffing, inadequate access to palliative medications, and restrictive visitation policies, and calls for proactive surge planning through organizational and policy reforms to facilitate symptom relief and comfort for patients dying in the pandemic.
This Viewpoint discusses the considerations and challenges affecting the palliative care specialty and delivery of palliative care in the COVID-19 era, as well as potential solutions.
This case series examines the clinical characteristics and outcomes of patients who received intervention by a novel coronavirus disease 2019 palliative care response team, focused on providing high-quality goals-of-care conversations in time-critical situations.
This Viewpoint describes the relevance of a palliative care approach to surgery during the coronavirus disease 2019 pandemic.
This prospective observational study assesses changes in treatment plans for patients with lung cancer and qualifies the types of changes observed as a direct result of the coronavirus disease 2019 pandemic.
This Viewpoint summarizes the clinical characteristics of patients with cancer as associated with increased mortality risk from COVID-19, and it highlights important areas where more research is needed.
In this Viewpoint, JAMA Internal Medicine editors offer a broad review of the clinical science emerging from the first 6 months of the coronavirus disease 2019 (COVID-19) pandemic, including epidemiology of the infection, evidence that has influenced clinical care, and a discussion of workforce and supply chain issues and health inequities affecting patients and essential workers.
This Viewpoint discusses the possibility that survivors of severe COVID-19 will experience persistent symptoms similar to those of post-sepsis syndrome and reviews best practices for promoting recovery from intensive care illness, including referral to physical and occupational therapy, medication optimization, and structured exercise.
This cross-sectional study examines changes in the number of patients with newly identified cancer before and during the coronavirus disease 2019 (COVID-19) pandemic in the United States.
In this narrative medicine essay, a palliative medicine physician reflects on what is gained and lost in the turn toward telemedicine during the COVID-19 pandemic from a cornerstone belief that the in-person encounter is an anchoring condition for the patient-physician relationship.
This cohort study of adults with COVID-19 examines factors associated with death and interhospital variation in treatment and outcomes in the US.
This Viewpoint discusses the long-standing deficiencies in nursing home financing and organization made worse by the spread of coronavirus disease 2019 (COVID-19), and proposes ways to improve testing and personal protective equipment availability, and payment reforms to incentivize quality care for residents and decrease emergency department and hospital use.
This Viewpoint discusses the second surge of COVID-19 patients on postacute care facilities and offers suggestions on how the medical community and policy makers should prepare by ensuring adequate infrastructure, staff training, and protective equipment.
This Viewpoint describes a framework for rationing ventilators during the COVID-19 pandemic should intensive care units find themselves with more patients than they can care for, using a score-based system that incorporates patients’ likelihood of surviving to hospital discharge and beyond and their role in the public health response to the outbreak.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: